Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Seminars in Cancer Biology|January 17, 2012
Monoclonal antibodies for the treatment of cancerCasey W Shuptrine, Rishi Surana, Louis M WeinerCell|March 20, 2012
Antibody-based immunotherapy of cancerLouis M Weiner, Joseph C Murray, Casey W ShuptrineEuropean Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Shining a LIGHT on myeloid cell targeted immunotherapyCasey W Shuptrine, Vincent M Perez, Sara R Selitsky, et al.Journal of Biomedical Materials Research. Part A|November 5, 2008
Influence of poly(D,L-lactic-co-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamberMeghan M Nickerson, Ji Song, Casey W Shuptrine, et al.Angiogenesis|September 25, 2009
Capillary arterialization requires the bone-marrow-derived cell (BMC)-specific expression of chemokine (C-C motif) receptor-2, but BMCs do not transdifferentiate into microvascular smooth muscleMeghan M Nickerson, Caitlin W Burke, Joshua K Meisner, et al.Cancer Immunology Research|December 20, 2019
CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive ImmunitySuresh de Silva, George Fromm, Casey W Shuptrine, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2017
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejectionCasey W Shuptrine, Reham Ajina, Elana J Fertig, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 8, 2009
Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodelingMeghan M Nickerson, Ji Song, Joshua K Meisner, et al.Cancer Research|May 6, 2020
IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with NeutrophilsTimothy N Trotter, Casey W Shuptrine, Li-Chung Tsao, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint BlockadeKyung Jin Yoo, Kellsey Johannes, Louis E González, et al.Pageof 2